Silvia Escribano Serrat, MD^1*, Paola Charry, MD^2*, Luis Gerardo Rodríguez-Lobato, MD, PhD^2*, Ana Belén Moreno-Castaño, MD, PhD Student^3*, María Suárez-Lledó, MD^2*, Nuria Martínez-Cibrian, MD^2*, María Teresa Solano^2*, Jordi Arcarons^2*, Meritxell Nomdedeu, MD^2*, Joan Cid^4*, Miquel Lozano, PhD^2*, Alexandra Pedraza^2*, Laura Rosiñol, MD, PhD^2*, Jordi Esteve, MD, PhD², Álvaro Urbano-Ispizua, MD, PhD², Marta Palomo, PhD^2*, Francesc Fernández-Avilés, MD^2*, Maria Carmen Martinez Munoz, PhD^2*, Maribel Diaz-Ricart, PhD^3*, Enric Carreras, MD, PhD^5*, Montserrat Rovira, MD, PhD^2* and María Queralt Salas, MD^6*

¹Department of Hematology and Hemotherapy, Hospital Clínico San Carlos, IdiSSC, Madrid, Spain
²Hematopoietic Transplantation Unit and Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
³Hematopathology, Pathology Department, CDB, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
⁴Apheresis & Cellular Therapy Unit, Department of Hemotherapy and Hemostasis, ICMHO, IDIBAPS, Hospital Clínic, Barcelona, Spain
⁵Fundació i Institut de Recerca Josep Carreras contra la leucèmia (Campus Clínic), Barcelona, Spain
⁶Hematopoietic Transplantation Unit and Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain

Erik Thiele Orberg, MD, PhD^1*, Elisabeth Meedt, MD^2*, Andreas Hiergeist^3*, Jinling Xue^4*, Paul Heinrich^5*, Sakhila Ghimire, BSc, MSc, PhD^6*, Melanie Tiefgraber^7*, Sophia Göldel^7*, Tina Eismann^7*, Alix Schwarz^8*, Sebastian Jarosch^9*, Katja Steiger^10*, Karin Kleigrewe^11*, Julius Clemens Fischer^12*, Klaus-Peter Janssen^13*, Michael Quante^14*, Simon Heidegger^15*, Peter Herhaus, MD^16*, Mareike Verbeek^17*, Jürgen Ruland^18*, Christian Schulz^19*, Daniela Weber, MD^20*, Matthias Edinger, MD, PhD^21*, Daniel Wolff, MD^21*, Dirk Busch^22*, Wolfgang Herr, MD²¹, Florian Bassermann^23*, Li Deng^4*, Andre Gessner^3*, Ernst Holler, MD, PhD²⁴ and Hendrik Poeck, MD²⁵

¹Department of Hematology and Oncology, University Hospital Rechts der Isar of the Technical University of Munich, Munich, Germany
²Blood and Marrow Transplantation Program, University Hospital Regensburg, Regensburg, DEU
³Institute of Clinical Microbiology and Hygiene, Regensburg, DEU
⁴Helmholtz Zentrum München, Munich, Germany
⁵University Hospital Regensburg, Regensburg, Germany
⁶University Hospital Regensburg, Regensburg, Bavaria, DEU
⁷University Hospital Rechts der Isar, Technical University of Munich, Munich, Germany
⁸University Hospital Rechts der Isar of the Technical University of Munich, Munich, Germany
⁹Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany
¹⁰Institute of Pathology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
¹¹Bavarian Center for Biomolecular Mass Spectrometry, Freising, Germany
¹²Department of Radiation Oncology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
¹³Department of Surgery, Technical University of Munich (TUM), School of Medicine, Klinikum rechts der Isar TUM, Munich, Germany
¹⁴University Hospital Freiburg, Freiburg, Germany
¹⁵Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany
¹⁶Internal Medicine III, School of Medicine, Klinikum rechts der Isar, Technische Universität München, München, Germany
¹⁷Technische Universitaet Muenchen, Munich, DEU
¹⁸Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany
¹⁹LMU University of Munich, Munich, DEU
²⁰Internal Medicine III, University Clinic Regensburg, Regensburg, Germany
²¹Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
²²Medical Microbiology, Immunology and Hygiene, Munich, DEU
²³Department of Internal Medicine III, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany
²⁴Department of Internal Medicine III, Univeristy Hospital Regensburg, Regensburg, Germany
²⁵Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Bavaria, Germany

Vladimir I. Vorobyev, MD¹, Anton Yu. Subora, MD^2*, Yulia A. Oleinik, MD^3*, Lev S. Butaev, MD^4*, Vera A. Zherebtsova, MD, PhD^2*, Darya G. Kisilichina, PhD^2*, Margarita A. Ulyanova, MD^2*, Evdokiya S. Urnova, MD^2*, Alena M. Sukhareva, MD^2* and Matvei P. Bulusov, MD^2*

¹Bone Marrow Transplant, Botkin Hospital, Moscow, Russia
²Bone Marrow Transplant, Botkin Hospital, Moscow, Russian Federation
³Botkin Hospital, Moscow, Russian Federation
⁴Bone Marrow transplant, Botkin Hospital, Moscow, Russian Federation

Huiying Qiu^1*, Jiahua Niu^1*, Xi Sun^1*, Huajun Li^2*, Juan Yang^1*, Chongmei Huang^1*, Yu CAI^1*, Kun Zhou^1*, Yin Tong^1*, Liping Wan^1* and Xianmin Song, phd^1*

¹Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, shanghai, China
²Clinical Research & Development, Jiangsu Hengrui pharmaceuticals Co., Ltd., shanghai, China

Maria Queralt Salas, MD^1,2*, Abel Santos Carreira, MD^3*, Eshetu G. Atenafu, M.Sc., P.Stat^4*, Tommy Alfaro Moya^3*, Arjun D. Law, MD^5*, Wilson Lam, MD^6*, Ivan Pasic^7*, Carol Chen^6*, Dennis Dong Hwan Kim, MD, PhD⁸, Fotios V. Michelis^9*, Armin Gerbitz^10*, Jeffrey H. Lipton¹¹, Rajat Kumar⁷, Jonas Mattsson^11* and Auro Viswabandya, MD, DM^12*

¹Hans Messner Allogenic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada
²Hematopoietic Cell Transplant Unit, Hospital Clinic de Barcelona, Barcelona, Spain
³Allogeneic Hematopoietic Cell Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada
⁴Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁵Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
⁶Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, Canada
⁷Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
⁸Hans Messner Allogeneic Blood and Marrow Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
⁹Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁰Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada
¹¹Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹²Hans Messner Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

A Samer Al-Homsi¹, Frank Cirrone^1*, Kelli Cole^1*, Jaime Andres Suarez-Londono^1*, Sharon L. Gardner^2*, Jingmei Hsu, MD, PhD^1*, Stephanie Wo^1*, Kelsey Stocker^1*, Benedetto Bruno, MD, PhD^3*, Judith Goldberg, ScD^4*, Benjamin Levinson^4* and Maher Abdul-Hay^1*

¹Blood and Marrow Transplantation and Cellular Therapy, New York University Langone Health, New York, NY
²Division of Pediatric Hematology and Oncology, Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders, NYU Langone Health, New York, NY
³Division of Hematoloty, University of Torino, Torino, Italy
⁴Department of Biostatistics, NYU Grossman School of Medicine, New York, NY

María Laura Fox, MD^1*, Alba Cabirta^2*, Ariadna Pérez Martínez^3*, Albert Esquirol, MD^4,5*, Marta Fonseca^6,7*, Víctor Navarro Garcés^8*, Inmaculada Heras, MD, PhD^9*, Leyre Bento, MD, PhD^10*, Aida Calo Pérez^11*, Teresa Zudaire, MD^12*, Maria Calbacho, MD^13*, Beatriz Gago^14*, Ana Pérez, MD^15*, Guillermo Ortí, MD, PhD^16,17,18*, Irene García-Cadenas, MD^19,20*, Lucía López Corral, MD^21*, José Navarro-Fernández^22*, Juan Montoro Gomez^23*, Antonia Sampol, MD²⁴, Carlos Solano, MD, PhD^25,26 and David Valcarcel, MD, PhD²⁷

¹Department of Hematology. Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron., Barcelona, Spain, Barcelona, Spain
²Servei D'Hematologia, Vall D'Hebron Hospital Universitari,, Barcelona, Spain
³Hematology Department, Hospital Universitario Clínico de Valencia, Valencia, Spain
⁴Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
⁵Universitat Autònoma de Barcelona, Barcelona, Spain
⁶Hematology Department, Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), Salamanca, Spain
⁷Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
⁸Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), BARCELONA, Spain
⁹Hematology Department, Hospital Universitario Morales Meseguer, Murcia, Spain
¹⁰Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
¹¹Hematology department, Hospital Clínico de San Carlos, Madrid, Spain
¹²Complejo Hospitalario de Navarra, Pamplona, Spain
¹³Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain, Spain
¹⁴Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain
¹⁵Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, Spain
¹⁶Department of Medicine. Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
¹⁷HU Vall d’Hebron, Barcelona, Spain
¹⁸Laboratory of Experimental Hematology, Department of Hematology. Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, BARCELONA, Spain
¹⁹Universidad Autónoma de Barcelona, Barcelona, Spain
²⁰Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
²¹Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
²²Hematology department, Hospital Morales Meseguer, MURCIA, Spain
²³Hospital Universitario La Fe, Valencia, Spain
²⁴Hematology and Hemotherapy Department, Son Espases University Hospital, IdISBa, Palma, Spain
²⁵Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
²⁶Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
²⁷Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain

Di Yao, MM^*, Jie Li, MD^*, Bohan Li, MM^*, Jun Lu, MD^*, Jing Ling, MD^*, Defei Zheng, MD^*, Peifang Xiao, MD^*, Lijun Meng, PhD^*, Shaoyan Hu, MD, PhD and Yuanyuan Tian^*

Department of Pediatric Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China

Zengkai Pan^1*, Yujun Deng^2*, Aijie Huang^3*, Zilu Zhang^1*, Luxiang Wang^1*, Hongbo Hu^2*, Jianmin Wang³ and Xiaoxia Hu^1*

¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
²Department of Neurology and Center for Immunology and Hematology, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, China
³Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, China

Hany Elmariah, MD, MS¹, Salman Otoukesh, MD^2*, Ambuj Kumar, MD, MPH^3*, Haris Ali, MD², Shukaib Arslan, MD^2*, Amrita Desai, MD^2*, Amanda Blackmon, DO, MS², Hoda Pourhassan, MD^2*, Taiga Nishihori, MD⁴, Rawan Faramand, MD⁴, Asmita Mishra, MD⁴, Farhad Khimani, MD⁴, Hugo F Fernandez, MD^5*, Aleksandr Lazaryan, MD, PhD, MPH⁴, Michael Nieder, MD^1*, Lia Perez, MD^1*, Hien D. Liu, MD¹, Ryotaro Nakamura, MD^2*, Joseph Pidala, MD, PhD⁴, Guido Marcucci, MD⁶, Stephen J Forman, MD², Claudio Anasetti, MD⁴, Frederick L. Locke, MD⁴, Nelli Bejanyan, MD⁴ and Monzr M. Al Malki, MD²

¹Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³Morsani College of Medicine, University of South Florida, Tampa, FL
⁴Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Pembroke Pines
⁶Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Thomas Luft, MD, PhD¹, Salim Oulghazi^2*, Caroline Pabst^3*, Leonard Petry^2*, Richard Huth^2*, Carsten Müller-Tidow, MD^1* and Peter Dreger, MD^4*

¹Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
²University Hospital Heidelberg, Heidelberg, Germany
³Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
⁴Department of Medicine V, University of Heidelberg, Heidelberg, Baden-Wuerttemberg, Germany

Adam Kuba^1*, Ludek Raida, MD, PhD^2*, Patrik Flodr^3*, Frantisek Mrazek^4*, Eva Kriegova, Dr, assoc prof^5*, Tomáš Papajík, MD, CSc, Prof^6* and Jiri Minarik, MD⁶

¹Department of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic, Olomouc, AL, Czech Republic
²Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
³2. Department of Clinical and Molecular Pathology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic, Olomouc, Czech Republic
⁴Department of Immunology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic, Olomouc, Czech Republic
⁵Department of Immunology, Faculty Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic
⁶Department of Hemato-oncology, Faculty Hospital and Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic

Annalisa Paviglianiti, MD^1,2*, Alberto Mussetti^3,4*, Maud Ngoya^5*, Ariane Boumendil, PhD^6,7*, Zafer Gulbas^8*, Fabio Ciceri, MD^9*, Francesca Bonifazi, MD^10*, Domenico Russo, MD¹¹, Nathalie Fegueux, MD^12*, Friedrich Stölzel^13*, Claude-Eric Bulabois, MD^14*, Gerard Socie, MD, PhD¹⁵, Edouard Forcade, MD, PhD¹⁶, Carlos Solano, MD, PhD^17,18, Hervé Finel^6*, Stephen Robinson, MD, PhD^19*, Silvia Montoto, MD^20,21 and Bertram Glass, MD^7,22*

¹Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, Barcelona, Spain
²Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain
³Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, Barcelona, Spain
⁴Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet De Llobregat, Barcelona, Spain
⁵Department of Hematology and Cell Therapy, EBMT Paris Study Office, Paris, France
⁶EBMT Lymphoma Working Party Paris Office, Paris, France
⁷Lymphoma Working Party, EBMT Central Registry Office, Paris, France
⁸Anadolu Medical Center Hospital, Bone Marrow Transplantation Department, Kocaeli, Turkey
⁹Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
¹⁰IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, NA, Italy
¹¹Unit of Blood Diseases and Bone Marrow Transplantation, ASST Spedali Civili, University of Brescia, ASST Spedali Civili, Brescia, Italy
¹²Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
¹³University Hospital, TU Dresden,Germany, Dresden, Germany
¹⁴Service d'Hématologie, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
¹⁵Department of Hematology – BMT, Hopital St. Louis, Paris, France
¹⁶Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France
¹⁷Department of Medicine, University of Valencia, Valencia, Spain
¹⁸Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
¹⁹University Hospital Bristol, Bristol, United Kingdom
²⁰EBMT Lymphoma Working Party and St. Bartholomew´s Hospital, Barts Health NHS Trust, London, United Kingdom
²¹Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom
²²Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany

Scott R. Solomon, MD¹, Lizamarie Bachier-Rodriguez, MD^1*, Xu Zhang, PhD^2*, H. Kent Holland, MD¹, Lawrence E. Morris Jr., MD^1*, Asad Bashey, MD, PhD¹ and Melhem Solh, MD¹

¹Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
²Center for Clinical and Transitional Sciences, University of Texas Health Science Center, Houston, TX

Rohtesh S. Mehta, MD¹, Rima M. Saliba, PhD^1*, Amin M Alousi, MD¹, Gheath Alatrash, PhD, DO², Qaiser Bashir, MD¹, Chitra Hosing, MD¹, Partow Kebriaei, MD¹, Issa F. Khouri, MD¹, Yago Nieto, MD³, Betul Oran, MD, MS⁴, Uday R Popat, MD¹, Muzaffar H Qazilbash, MD¹, Jeremy L. Ramdial, MD¹, Gabriela Rondon, MD⁵, Samer A Srour, MD, MS⁶, Katy Rezvani, MD¹, Richard E Champlin, MD¹, Elizabeth J Shpall, MD¹ and Kai Cao, MS, MD⁷

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Pearland, TX
³Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
⁴Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
⁷Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Ruihao Huang^1*, Ting Chen^1*, Sanbin Wang^2*, Jishi Wang, PhD³, Yi Su, MD^4*, Jing Liu, M.D., Ph.D.^5*, Peiyan Kong^6*, Cheng Zhang, MD, PhD^7*, Lei Gao^8*, Li Gao^8* and Xi Zhang, MD, PhD^1*

¹Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
²920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, China
³Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang City, China
⁴General Hospital of Chengdu Military Region of People’s Literation Arm, Chengdu, China
⁵Department of Hematology, Third Xiangya Hospital of Central South University, Changsha, China
⁶Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China, Chongqing, China
⁷Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, Chongqing, China
⁸Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, chongqing, China

Sharmila Raghunandan, DO, MPH¹, Lev Gorfinkel, MD², Michael Graiser, PhD^3*, Brandi Bratrude, BA^2*, Kayla Betz, BS, MPH^4*, Yvonne Suessmuth, PhD^1*, Scott Gillespie, MS^5*, Adrianna Lynn Westbrook, MPH^5*, Kirsten M. Williams, MD¹, Michelle Schoettler, MD^1*, Amelia Langston, MD⁶, Leslie Kean, MD, PhD⁷, Muna Qayed, MD, MSc⁸, John T. Horan, MD, MPH² and Benjamin Watkins, MD¹

¹Emory University, Children’s Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Atlanta, GA
²Dana-Farber Cancer Institute, Boston Children’s Hospital, Boston, MA
³Department of Hematology and Medical Oncology, Winship Cancer Institute, Atlanta, GA
⁴Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston
⁵Pediatric Biostatics Core, Emory University, Atlanta, GA
⁶Emory University, Winship Cancer Institute, Atlanta, GA
⁷Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston
⁸Emory University, Atlanta, GA

Everett H Meyer, MD, PhD^1*, M Scott Killian, PhD^2*, Anna Pavlova, MD, PhD^3*, Cameron Bader^3*, Sean Summers^2*, Fernando Teque^2*, J Scott McClellan, MD, PhD² and Nathaniel B Fernhoff, PhD^2*

¹Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
²Orca Bio, Menlo Park, CA
³Stanford University, Stanford, CA

Hannah Choe, MD¹, Nicholas Yuhasz, MS^1*, Greer Elizabeth Miller^1*, Me'kayla Travis^2*, Avinash Karanth, PhD^2*, Kyle Shifflet^2* and Parvathi Ranganathan, PhD¹

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²School of Electrical Engineering and Computer Science, Ohio University, Athens, OH

Valentin Letailleur^1*, Amandine Le Bourgeois, PhD^2*, Thierry Guillaume, MD, PhD^2*, Pierre Peterlin, MD^3*, Alice Garnier, MD^4*, Maxime Jullien, MD^5*, Marianne Coste-Burel, MD, PhD^6*, Marie C Béné, PharmSciD, PhD^7* and Patrice Chevallier, MD⁴

¹Clinical Hematology Department, Nantes University Hospital, Angers, France
²Clinical Hematology Department, Nantes University Hospital, Nantes, France
³Clinical Hematology, Nantes University Hospital, Nantes, France
⁴Hematology Department, Nantes University Hospital, Nantes, France
⁵Clinical Hematology, Nantes University Hospital, NANTES, France
⁶Virology, Nantes University Hospital, Nantes, France
⁷Biology Department, Nantes University Hospital, Nantes, France

Alistair Murray¹, Swe Mar Linn, MBBS², Benoit Yu^3*, Igor Novitzky-Basso, MD⁴, Jonas Mattsson^4*, Mohamed Elemary, MD^5*, Jennifer White, MD, MSc, FRCPC^6*, Christopher Lemieux, MD⁷, Kareem Jamani, MD^1* and Dennis Kim, MD, PhD⁴

¹Division of Hematology and Hematologic Malignancies, University of Calgary, Calgary, AB, Canada
²Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, Canada
³Laval University, Quebec, QC, Canada
⁴Hans Messner Allogeneic Blood and Marrow Transplant Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵University of Saskatchewan, Saskatoon, Canada
⁶The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada
⁷Centre intégré de cancérologie, CHU de Québec - Université Laval, Quebec, QC, Canada

Omar Albanyan, MD^1,2, Syeda Mahrukh Hussnain Naqvi, MD, MHS^3*, Qianxing Mo, PhD^3*, Athena Belfon^4*, Eric Gaskill, PharmD^2*, Taiga Nishihori, MD⁵, Rawan Faramand, MD², Aleksandr Lazaryan, MD, PhD, MPH², Doris K. Hansen, MD⁵, Farhad Khimani, MD², Asmita Mishra, MD², Michael Nieder, MD^5*, Lia Perez, MD^5*, Hien D. Liu, MD⁵, Joseph Pidala, MD, PhD², Claudio Anasetti, MD², Frederick L. Locke, MD², Nelli Bejanyan, MD² and Hany Elmariah, MD, MS⁵

¹Adult Hematology- Oncology and SCT, King Fahad Specialist Hospital., Dammam, Saudi Arabia
²Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴H. Lee Moffitt Cancer Center & Research Institute, Tampa
⁵Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL